I recently caught up with my longtime friend and colleague, Norman Goldfarb. Norm is well-known to all of us in the clinical trials industry as an innovator and a best-practice thought leader for fostering clinical trial site relationships with sponsors and CROs. Norm’s resume is…
Clinical trial teams must be agile and proactive in the evolving world of clinical studies. Research teams navigating today’s dynamic landscape face a multitude of risks due to the ever-increasing pace of change. These risks can include: Technological advances rapidly rendering initial plans obsolete Supply…
With more than 65,000 clinical studies currently recruiting, our industry is constantly working hard to enroll participants and meet study timelines. Unfortunately, public skepticism in clinical trials can get in the way of those efforts. People enroll in studies for a variety of reasons, from…
Today, companies and industries grapple with the impact of three key types of sustainability in business. These factors are called ESG, another acronym for the clinical trial industry, already loaded with acronyms. This one, though, carries across industries and impacts everyone. ESG stands for environmental,…
Company values are guiding principles, the foundation that provides alignment toward a common purpose. At Imperial Clinical Research Services, everything we do is rooted in our company values, which are integral to our success. Imperial’s six values are an extremely important piece of our culture.…